Evidence map›Paper›PMID 41994283›Full record

ArticleFrontiers in microbiology2026

Phage amplification-coupled CRISPR/Cas12a system for selective detection of viable

Nicharee Wisuthiphaet, Ahmed El-Moghazy, Nitin Nitin

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicharee WisuthiphaetDepartment of Biotechnology, Faculty of Applied Science, King Mongkut's University of Technology North Bangkok, Bangkok, Thailand.
Ahmed El-MoghazyDepartment of Microbiology and Plant Pathology, University of California, Riverside, Riverside, CA, United States.
Nitin NitinDepartment of Food Science and Technology, University of California, Davis, Davis, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid and specific detection of viable foodborne pathogens is critical for ensuring the safety of the food supply chain and preventing the risk of foodborne illness outbreaks. In this study, bacteriophage T7 amplification was integrated with a CRISPR/Cas12a-based assay for detecting viable

Indexed as

bacterial detectionbacteriophageCRISPR/Cas12aE. colifood safety

Identifiers

PMID41994283
PMCPMC13079353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.